As of 2025-12-15, the Intrinsic Value of Replimune Group Inc (REPL) is -19.76 USD. This REPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.18 USD, the upside of Replimune Group Inc is -294.06%.
Based on its market price of 10.18 USD and our intrinsic valuation, Replimune Group Inc (REPL) is overvalued by 294.06%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -19.76 - -19.76 | -19.76 | -294.06% |
| P/E | (67.96) - (96.41) | (92.36) | -1007.2% |
| DDM - Stable | (30.79) - (120.72) | (75.75) | -844.1% |
| DDM - Multi | (1.26) - (3.85) | (1.90) | -118.6% |
| Market Cap (mil) | 798.52 |
| Beta | 0.39 |
| Outstanding shares (mil) | 78.44 |
| Enterprise Value (mil) | 768.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.96% |
| Cost of Debt | 5.00% |
| WACC | 9.55% |